Abstract | OBJECTIVE: METHODS: A 56-week multicentre factorial-design double-blind placebo-controlled RCT compared steroids alone, MTX (15-25 mg weekly) plus steroids, ciclosporin (1-5 mg/kg/day) plus steroids and all three treatments. It enrolled adults with myositis (by Bohan and Peter criteria) with active disease receiving corticosteroids. RESULTS: A total of 359 patients were screened and 58 randomized. Of the latter, 37 patients completed 12 months of treatment, 7 were lost to follow-up and 14 discontinued treatment. Patients completing 12 months of treatment showed significant improvement (P < 0.001 on paired t-tests) in manual muscle testing (14% change), walking time (22% change) and function (9% change). Intention to treat and completer analyses indicated that ciclosporin monotherapy, MTX monotherapy and ciclosporin/MTX combination therapy showed no significant treatment effects in comparison with placebo. CONCLUSION: TRIAL REGISTRATION: International Standard Randomized Controlled Trial Number Register; http://www.controlled-trials.com/; ISRCTN40085050.
|
Authors | Fowzia Ibrahim, Ernest Choy, Patrick Gordon, Caroline J Doré, Alan Hakim, George Kitas, David Isenberg, Bridget Griffiths, Bryan Lecky, Kuntal Chakravarty, John Winer, Katalin Danko, Robert G Cooper, Beverley White-Alao, David L Scott |
Journal | Rheumatology (Oxford, England)
(Rheumatology (Oxford))
Vol. 54
Issue 6
Pg. 1050-5
(Jun 2015)
ISSN: 1462-0332 [Electronic] England |
PMID | 25433040
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | © The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. |
Chemical References |
- Adrenal Cortex Hormones
- Immunosuppressive Agents
- Cyclosporine
- Methotrexate
|
Topics |
- Adrenal Cortex Hormones
(therapeutic use)
- Cyclosporine
(therapeutic use)
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Humans
- Immunosuppressive Agents
(therapeutic use)
- Male
- Methotrexate
(therapeutic use)
- Myositis
(drug therapy)
- Treatment Outcome
|